Innovative Cardiovascular Health Program

Innovative Cardiovascular Health Program is sponsored by Centers for Disease Control and Prevention (CDC) National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP). This program focuses on health system interventions aimed at preventing, controlling, and managing high blood pressure and high blood cholesterol.

Expired RFA-DP-06-003: Health Promotion and Disease Prevention Research Centers: Special Interest Project Competitive Supplements This notice has expired. Check the NIH Guide for active opportunities and notices. Part I Overview Information Department of Health and Human Participating Organizations Centers for Disease Control and Prevention (CDC), ( http://www.

cdc. gov/ ) Components of Participating Organizations National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), ( http://www. cdc.

gov/nccdphp/ ) Disease Prevention Research Centers Program (PRC), ( http://www. cdc. gov/prc/ ) Promotion and Disease Prevention Research Centers: Special Interest Project CDC policies, guidelines, terms, and conditions stated in this announcement may differ from those used by the NIH .

Awards are made under the authorization of Public Health Service Act, Section 1706, 42 U.S.C. 300u-5, as amended; Section 2(d), Public Law 98-551. Announcement Type: This is a supplement to Program Announcement 04-003 which was released on March 27, 2003 .

Request For Applications (RFA) Number: RFA-DP-06-003 Catalog of Federal Domestic Assistance Number(s): 93.

135 Letter of Intent Receipt Date: April 19 , 2006 Receipt Date: May 19 , 2006 Peer Review Date: Week of Ju ne 26 , 2006 Review Date: Week of July 1 7 , 2006 Anticipated Start Date: September 30, Expiration Date: 05 / 20 /2006 Executive Order 12372 does not apply to This RFA will provide supplemental funding to Prevention Research Centers to design, test, and disseminate effective prevention research strategies in the areas of cancer, reproductive health, child and adolescent health, and adult health.

The total amount to be awarded: $1 ,850,000 in FY06. The anticipated number of awards: 9 Special Interest Projects This funding opportunity will use the cooperative agreement funding mechanism (CDC U48). Prevention Research Centers funded under CDC Program Announcement 04-003 are eligible to compete for SIP supplemental funding.

Individuals with the skills, knowledge, and resources necessary to conduct the proposed research are invited to work with the eligible organizations to develop an application. Individuals from underrepresented racial or ethnic groups as well as individuals with disabilities are always encouraged to apply for CDC programs.

A Prevention Research Center may apply for multiple Special Interest Projects; however, a separate application must be submitted for each SIP. A PRC may submit only one application per SIP. See Section IV.

1 for application materials. Telecommunications for the hearing impaired is available at: TTY 770-488-2783. If NIH is involved, even as a collaborator, include the NIH Telecommunications number: TTY 301-451-5936.

Part I Overview Information II Full Text of Announcement I. Funding Opportunity Description III. Eligibility Information 3.

Other - Special Eligibility Criteria IV. Application and Submission Information Address to Request Application Information Content and Form of Application Submission Submission Dates and Times A. Receipt and Review and Anticipated Start Dates B.

Sending an Application C. Application Processing Other Submission Requirements V. Application Review Information Review and Selection Process A.

Additional Review Criteria B. Additional Review Considerations D. Sharing Research Resources Anticipated Announcement and Award Dates VI.

Award Administration Information Administrative and National Policy Requirements A. Cooperative Agreement Terms and Conditions of Award 1. Principal Investigator Rights and 3.

Collaborative Responsibilities Scientific/Research Contact(s) Financial/ Grants Management Contact(s) 4. General Questions Contact(s) Section VIII. Other Information - Required Federal Section IX.

Special Interest Projects (SIPs) Description and Objectives Criteria and Funding Preferences Proposal Length and Supporting Material Section I.

Funding Opportunity The CDC and the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) are committed to achieving the health promotion and disease prevention objectives of "Healthy People 2010" and to measuring program performance as stipulated by the Government Performance and Review Act (GPRA).

This RFA addresses Healthy People 2010 priority areas of Access to Quality Health Services, Public Health Infrastructure, Cancer, Disability and Secondary Conditions, Educational and Community-Based Programs, Family Planning, Sexually Transmitted Diseases, Nutrition and Overweight, Adolescent Health, and Heart Disease and Stroke and is in alignment with the NCCDPHP performance goal to support prevention research to develop sustainable and transferable community-based behavioral interventions .

For more information, This program also addresses the department-wide initiative, Steps to a HealthierUS , which advances the HealthierUS goal of helping Americans live longer, better and healthier lives by focusing on the importance of prevention.

The Steps initiative envisions a healthy, strong U.S. population supported by a health care system in which diseases are prevented when possible, controlled when necessary, and treated when appropriate. This funding opportunity supports the Steps focus areas of Physical Fitness, Nutrition, and Prevention.

of the Research Opportunity This RFA builds upon the infrastructure of the Prevention Research Centers (PRC) program and solicits applications in the form of cooperative agreements to support supplemental health promotion and disease prevention research projects that: 1) focus on the major causes of death and disability; 2) improve public health practice within communities; and 3) cultivate effective state and local public health programs.

Special Interest Projects (SIPs) provide supplemental funding to the PRCs to design, test, and disseminate effective prevention research strategies in the areas of cancer, reproductive health, child and adolescent health, and adult health. the US population ages and health care costs increase, prevention becomes even more critical to the national health care agenda.

Many chronic diseases, injuries, and some infectious diseases are caused by behavioral and environmental factors that can be changed. Prevention research is critical to helping people change risk factors in their lives and their communities.

The gaps between research findings and their translation into public health programs, practice, and policy must be eliminated so that new knowledge is effectively applied in states and communities throughout the country. In 1984 Congress authorized HHS to create a network of academic health centers to conduct applied public health research.

CDC was selected to administer the Prevention Research Centers (PRC) program and to provide leadership, technical assistance, and oversight. Today, the PRCs comprise a national network of 33 academic-based research centers that are committed to community-based participatory research and to the translation of research into programs and policies.

The PRC infrastructure and their various research projects are supported by CDC and guided by community committees. The consortium of academic, public health, and community partners engages in community-based prevention research, research translation, and education to address the leading causes of death and disability. The combined research portfolio for the 33 PRCs includes nearly 500 projects across the country.

The partnerships and expertise each PRC builds strengthens its competitiveness for additional funding by federal agencies and private foundations. The Special Interest Projects (SIPs) mechanism, created in 1993, allow the PRCs to compete for research projects sponsored by CDC organizational units and other HHS agencies that want to utilize their resources to fund research that promotes better public health practice in specific areas.

Typically, SIPs are funded for a minimum of one year and $100,000; however, there are many SIPs that are multi-year endeavors to which several million dollars are dedicated.

The SIP mechanism is designed to maximize on the expertise and resources offered by each center and the PRC network as a Scientific Knowledge to be achieved through this Funding Opportunity This RFA is expected to fund research that will expand our knowledge and understanding in the areas of cancer, reproductive health, child and adolescent health, and adult health. Individual project descriptions are contained in Section IX .

Special Interest Projects (SIPs) Descriptions of this announcement. SIP descriptions are grouped by the Health Special Interest Projects 3-4 and Adolescent Health Special Interest Projects 5 Health Special Interest Projects 6-8 SIP has specific anticipated outcomes and/or expected deliverables. Please refer to the Project Activities of the SIP description in Section IX .

Special Interest Projects (SIPs) Descriptions of this announcement. Experimental Approach and Research Objectives research objectives of the SIPs are in alignment with the performance goal for the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP): To support prevention research to develop sustainable and transferable community-based behavioral interventions.

The experimental approach and objectives for each SIP are detailed in Section IX . Special Interest Projects (SIPs) Descriptions of this announcement under Project Descriptions and Objectives of the SIP description. See Section VIII.

Other Information - Required Federal Citations , for policies related to this announcement. 1. Mechanism(s) of Support funding opportunity will use the CDC U48 award mechanism.

funding opportunity uses the just-in-time budget concepts. It also uses the non-modular budget format described in the PHS 398 application instructions (see http://grants. nih.

gov/grants/funding/phs398/phs398. html ). A detailed categorical budget for the "Initial Budget Period" and the "Entire Proposed Period of Support" is to be submitted with the CDC U48 is a cooperative agreement award mechanism.

In the cooperative agreement mechanism, the Principal Investigator retains the primary responsibility and dominant role for planning, directing, and executing the proposed project, with CDC staff being substantially involved as a partner with the Principal Investigator, as described under the Section VI. 2 . Administrative Requirements, "Cooperative Agreement Terms and Conditions RFA is a one-time solicitation.

The NCCDPHP intends to commit approximately $1,850,000 in FY06 to fund approximately nine cooperative agreements ranging in total costs, direct and indirect, from $100,000 to $350,000 in response to this funding opportunity. Because t he nature and scope of the proposed research will vary by SIP, and from application to application, it is anticipated that the size and duration of each award will vary.

In previous years, the amount of funding per SIP has ranged from $100,000 to $1,250,000. anticipated start date for each SIP is September 30, 2006. Performance periods will vary by SIP.

The performance period for each SIP is detailed in Section IX . Special Interest Projects (SIPs) Descriptions of this announcement under Availability of Funds of the SIP description.

Following is a list of the SIPs, their titles, and total funding amounts (direct and indirect) for the first 12-month budget SIP 1: Inventory and Assessment of National Breast and Cervical Cancer Early Detection Program (NBCCEDP) Interventions ($250,000) Evaluation of an Existing Cancer Survivorship Educational Material into a Clinical Setting ($200,000) SIP 3: Identifying intervention needs of youth living in communities with high rates of teen pregnancy ($300,000) SIP 4: Intervention Research on Youth Development to Prevent Teen SIP 5: Building Capacity for Community Monitoring System to Track Indicators of Child and Adolescent Well-being ($200,000 to fund two projects) SIP 6: Reliability Study of the Actions to Control High Blood Pressure Module in the Behavioral Risk Factor Surveillance System ($100,000) SIP 7: Intervention Research on Home-based Depression Treatment in People with Epilepsy ($200,000) SIP 8: Identification and Development of Prevention Opportunities to Promote or Maintain Brain Health in estimated funding amounts are subject to availability of funds.

will accept and review applications with budgets greater than the listed funding amount for the SIP. III. Eligibility Information applicants who have applied for and have been selected as Prevention Research Centers under CDC Program Announcement 04-003 are eligible to compete for the Special Interest Project (SIP) supplemental funding.

Competition is limited to Prevention Research Centers funded under PA 04-003 because they are uniquely positioned to perform, oversee, and coordinate community-based participatory research that promotes the field of prevention research due to their established relationships with community partners.

The supplemental projects in this RFA complement ongoing prevention research projects being conducted as part of the CDC Prevention Research Program. individual with the skills, knowledge, and resources necessary to carry out the proposed research is invited to work with their institution to develop an application for support.

Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply 2. Cost Sharing or Matching funds, or cost participation are not required under this program. most current Grants Policy Statement can be found at: http://grants.

nih. gov/grants/policy/gps/ 3. Other-Special Eligibility Criteria application is incomplete or non-responsive to the special requirements listed in this section, it will not be entered into the review process.

Title 2 of the United States Code Section 1611 states that an organization described in Section 501(c)(4) of the Internal Revenue Code that engages in lobbying activities is not eligible to receive Federal funds constituting an IV. Application and Submission Information 1. Address to Request Application application instructions are available at: http://grants.

nih. gov/grants/funding/phs398/phs398. html in an interactive format.

Applicants must use the currently approved version of the PHS 398. For further assistance contact GrantsInfo, Telephone (301) 710-0267, Email: [email protected] . CDC Telecommunications for the hearing impaired: TTY 770-488-2783.

2. Content and Form of Application Submission Applications must be prepared using the most current PHS 398 research grant application instructions and forms. Applications must have a Dun & Bradstreet (D&B) Data Universal Numbering System number as the universal identifier when applying for Federal grants or cooperative agreements.

The D&B number can be obtained by calling (866) 705-5711 or through the web site at http://www. dnb. com/us/ .

The D&B number should be entered on line 11 of the face page of the PHS 398 of this funding opportunity must be typed on line 2 of the face page of the application form and the YES box must be checked. 3. Submission Dates and Times All requested information must be received in the CDC Procurement and Grants Office by 4:00 p.

m. Eastern Time on the deadline date. If you submit your application by the United States Postal Service or commercial delivery service, you must ensure that the carrier will be able to guarantee delivery by the closing date and time.

If CDC receives your submission after closing due to: (1) carrier error, when the carrier accepted the package with a guarantee for delivery by the closing date and time, or (2) significant weather delays or natural disasters, you will be given the opportunity to submit documentation of the carrier’s guarantee.

If the documentation verifies a carrier problem, CDC will consider the submission as having been received by the deadline. This announcement is the definitive guide on LOI and application content, submission address, and deadline. It supersedes information provided in the application instructions.

If your application does not meet the deadline described in Section IV. 3. A , it will not be eligible for review, and will be discarded.

You will be notified that you did not meet the Otherwise, CDC will not notify you upon receipt of your submission. If you have a question about the receipt of your application, first contact your courier. If you still have a question, contact the PGO-TIMS staff at: 770-488-2700.

Before calling, please wait two to three days after the submission deadline. This will allow time for submissions to be processed 3. A.

Receipt, Review and Anticipated Start Dates of Intent Receipt Date: April 19, 2006 Receipt Date: May 19, 2006 Peer Review Date: Week of June 26, 2006 Council Review Date: Week of July 17, 2006 Earliest Anticipated Start Date: September 30, 2006 Prospective applicants are asked to submit a letter of intent that includes the following information: title of proposed research. and telephone number of the Principal Investigator.

title of this funding opportunity letter of intent is not required , is not binding, and does not enter into the review of a subsequent application, the information that it contains allows CIO staff to estimate the potential review workload and plan letter of intent is to be sent by the date listed in Section IV. 3.

A letter of intent should be sent to: Brenda Colley Gilbert, PhD, MSPH Center for Chronic Disease Prevention and Health Promotion Center-Williams Building, MS K-92 follow the PHS 398 application instructions for content and formatting of your applications. If the instructions in this announcement differ in any way from the PHS 398 instructions, follow the instructions in this announcement.

must be prepared using the research grant applications found in the PHS 398 instructions for preparing a research grant application.

Submit a signed, typewritten original of the application and all appendices, including the checklist, and one signed photocopy in one package to: Information Management Section RFA DP-06-003 CDC, Procurements and Grants Office At the time of submission, three additional copies of the application, including the appendix material, must be sent to: Office of Extramural Research National Center for Chronic Disease Prevention and Health Promotion Center-Williams Building, MS K-92 must be received on or before the application receipt date(s) described above ( Section IV.

3. A. ).

If an application is received after that date, it will be returned to the applicant without review. Upon receipt, applications will be evaluated for completeness and responsiveness by NCCDPHP and PGO. Incomplete and non-responsive applications will not be reviewed.

4. Intergovernmental Review Executive Order 12372 does not apply to this program. CDC awards are subject to the terms and conditions, cost principles, and other considerations described in the PHS Grants Policy Statement.

Restrictions, which must be taken into account while writing your budget, are as follows: Funds relating to the conduct of research will be restricted until the appropriate assurances and Institutional Review Board Reimbursement of pre-award costs is not allowed. 6. Other Submission Requirements apply for multiple Special Interest Projects; however, a separate application must be submitted for each SIP.

The application must clearly indicate which SIP you are applying for. Only one application per Special Interest Project will be accepted from a PRC. Awardees must agree to the "Cooperative Agreement Terms and Conditions of Award" in Section VI .

"Award Administration Information" . If you are requesting indirect costs in your budget, you must include a copy of your indirect cost rate agreement. If your indirect cost rate is a provisional rate, the agreement should be less than 12 months of age.

Your research plan should address activities to be conducted over the entire project period. The precise content of the data-sharing plan will vary, depending on the data being collected and how the investigator is planning to share the data.

Applicants may wish to describe briefly the expected schedule for data sharing, the format of the final dataset, the documentation to be provided, whether or not any analytic tools also will be provided, whether or not a data-sharing agreement will be required and, if so, a brief description of such an agreement (including the criteria for deciding who can receive the data and whether or not any conditions will be placed on their use), and the mode of data sharing (e.g., under their own auspices by mailing a disk or posting data on their institutional or personal website, through a data archive or enclave).

References to data sharing may also be appropriate in other sections of the application. All applicants must include a plan for sharing research data in their application. The data sharing policy is available at http://www.

cdc. gov/od/pgo/funding/ARs. htm under Additional Requirements 25 Release and Sharing of Data.

All investigators responding to this funding opportunity should include a description of how final research data will be shared, or explain why data sharing is not reasonableness of the data sharing plan or the rationale for not sharing research data will be assessed by the reviewers. However, reviewers will not factor the proposed data sharing plan into the determination of scientific merit or the priority score.

policy requires that grant award recipients make unique research resources readily available for research purposes to qualified individuals within the scientific community after publication (PHS Grants Policy Statement http://grants. nih. gov/grants/policy/gps/8postnew.

htm#phs . ) Investigators responding to this funding opportunity should include a plan for sharing research resources addressing how unique research resources will be shared or explain why sharing adequacy of the resources sharing plan and any related data sharing plans will be considered by Program staff of the funding organization when making recommendations about funding applications.

The effectiveness of the resource sharing will be evaluated as part of the administrative review of each non-competing Grant Progress Report (PHS 2590, http://www. cdc. gov/od/pgo/forminfo.

htm ). See Section VI. 3.

Reporting . V. Application Review Information Only the review criteria described below will be considered in the review process.

The following will be considered in making funding merit of the proposed project as determined by peer review 2. Review and Selection Process that are complete and responsive to the RFA will be evaluated for scientific and technical merit by an appropriate peer review group convened by NCCDPHP in accordance with the review criteria stated below.

part of the initial merit review, all applications will: Undergo a selection process in which only those applications deemed to have the highest scientific merit, generally the top half of applications under review, will be discussed and assigned a priority Receive a written critique. Receive a second level of review by a Secondary Review Committee convened by NCCDPHP.

of CDC-supported research are to advance the understanding of health promotion and prevention of disease, injury, and disability, and enhance preparedness. In the written comments, reviewers will be asked to evaluate the application in order to judge the likelihood that the proposed research will have a substantial impact on the pursuit of these goals. study address an important problem?

If the aims of the application are achieved, how will scientific knowledge or clinical practice be advanced? What will be the effect of these studies on the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field? conceptual or clinical framework, design, methods, and analyses adequately developed, well integrated, well reasoned, and appropriate to the aims of the project?

Does the applicant acknowledge potential problem areas and consider Innovation: Is the project original and innovative? For example: Does the project challenge existing paradigms or clinical practice; address an innovative hypothesis or critical barrier to progress in the field? Does the project develop or employ novel concepts, approaches, methodologies, tools, or technologies for this area?

investigators appropriately trained and well suited to carry out this work? Is the work proposed appropriate to the experience level of the principal investigator and other researchers? Does the investigative team bring complementary and integrated expertise to the project (if applicable)?

scientific environment in which the work will be done contribute to the probability of success? Do the proposed studies benefit from unique features of the scientific environment, or subject populations, or employ useful collaborative arrangements? Is there evidence of institutional support?

addition to the above criteria, the following items will continue to be considered in the determination of scientific merit and the priority score: Does the applicant adequately address the preferences detailed in the Special Interest Project they are applying for? SIP preferences are detailed in Section IX .

Special Interest Projects (SIPs) Descriptions of this announcement under Additional Review Criteria and Funding Preferences of the SIP description . Protection of Human Subjects from Research Risk : The involvement of human subjects and protections from research risk relating to their participation in the proposed research will be assessed (see the Research Plan, Section E on Human Subjects in the PHS Form 398). http://www.

hhs. gov/ohrp/humansubjects/guidance/45cfr46. htm .

Additional CDC Requirements under AR-1 Human Subjects Requirements can be found on http://www. cdc. gov/od/pgo/funding/ARs.

htm . Women and Minorities in Research: the application adequately address the CDC Policy requirements regarding the inclusion of women, ethnic, and racial groups in the proposed research?

This includes: (1) The proposed plan for the inclusion of both sexes and racial and ethnic minority populations for appropriate representation; (2) The proposed justification when representation is limited or absent; (3) A statement as to whether the design of the study is adequate to measure differences when warranted; and (4) A statement as to whether the plans for recruitment and outreach for study participants include the process of establishing partnerships with community(ies) and recognition of mutual benefits.

materials or procedures are proposed that are potentially hazardous to research personnel and/or the environment, determine if the proposed protection is Budget: The reasonableness of the proposed budget and the requested period of support in relation to the proposed research.

The priority score should not be affected by the evaluation of the Data Sharing Plan: The reasonableness of the data sharing plan or the rationale for not sharing research data will be assessed by the reviewers. However, reviewers will not factor the proposed data sharing plan into the determination of scientific merit or the priority score. The presence of a data sharing plan will be part of the terms and conditions of the award.

The funding organization will be responsible for monitoring the data policy requires that grant award recipients make unique research resources readily available for research purposes to qualified individuals within the scientific community after publication. http://grants. nih.

gov/grants/policy/gps/8postnew. htm#phs . Investigators responding to this funding opportunity should include a sharing research resources plan addressing how unique research resources will be shared or explain why sharing is not possible.

staff will be responsible for the administrative review of the plan for sharing adequacy of the resources sharing plan will be considered by Program staff of the funding organization when making recommendations about funding applications. Program staff may negotiate modifications of the data and resource sharing plans with the awardee before recommending funding of an application.

The final version of the data and resource sharing plans negotiated by both will become a condition of the award of the grant. The effectiveness of the resource sharing will be evaluated as part of the administrative review of each non-competing Grant Progress Report (PHS 2590 http://www. cdc.

gov/od/pgo/forminfo. htm ). See Section VI.

3. Reporting . 3.

Anticipated Announcement and Award Dates expects to announce awards on or about September 30, 2006. VI. Award Administration Information the peer review of the application is completed, the Principal Investigator will also receive a written critique called a Summary Statement.

under consideration for funding will be contacted by CDC for additional A formal notification in the form of a Notice of Award (NoA) will be provided to the applicant organization. The NoA signed by the Grants Management Officer (GMO) is the authorizing document.

This document will be mailed and/or emailed to the recipient fiscal officer identified in the Selection of the application for award is not an authorization to begin performance. Any cost incurred before receipt of the NoA is at the recipient’s risk. These costs may be reimbursed only to the extent considered allowable pre-award costs.

See also Section IV. 5. Funding National Policy Requirements The Code of Federal Regulations 45 CFR Part 74 and Part 92 have details about policy requirements.

For more information on the Code of Federal Regulations, see the National Archives and Records Administration at the following Internet address: http://www. access. gpo.

gov/nara/cfr/cfr-table-search. html . Additional requirements can be found in Section VIII .

Other Information of this document or on the CDC website at the following Internet address: http://www. cdc. gov/od/pgo/funding/ARs.

htm . These will be incorporated into the NoA by reference. Agreement Terms and Conditions of Award The following special terms of award are in addition to, and not in lieu of, otherwise applicable OMB administrative guidelines, HHS grant administration regulations at 45 CFR Parts 74 and 92 (Part 92 is applicable when State and local Governments are eligible to apply), and other HHS, PHS, and CDC grant administration policies.

and funding instrument used for this program will be the cooperative agreement U48 an "assistance" mechanism (rather than an "acquisition" mechanism), in which substantial CDC programmatic involvement with the awardees is anticipated during the performance of the activities.

Under the cooperative agreement, the CDC purpose is to support and stimulate the recipients' activities by involvement in and otherwise working jointly with the award recipients in a partnership role; it is not to assume direction, prime responsibility, or a dominant role in the activities.

Consistent with this concept, the dominant role and prime responsibility resides with the awardees for the project as a whole, although specific tasks and activities may be shared among the awardees and the CDC as defined above. 2. A.

1. Principal Investigator Rights and The rights and responsibilities of the Principal Investigator are delineated in Section IX . Special Interest Projects (SIPs) Descriptions of this announcement under Award Administration of the SIP description.

Awardees will retain custody of and have primary rights to the data and software developed under these awards, subject to Government rights of access consistent with current HHS, PHS, and CDC policies. 2. A.

2. CDC Responsibilities NCCDPHP Project Scientist will have substantial programmatic involvement that is above and beyond the normal stewardship role in awards. Each SIP lists specific responsibilities and applicants should refer to Section IX .

Special Interest Projects (SIPs) Descriptions of this announcement under Award Administration of the SIP description for details. Additionally, an agency program official or CIO program director will be responsible for the normal scientific and programmatic stewardship of the award and will be named in the award notice. 2.

A. 3. Collaborative Responsibilities collaborative responsibilities.

Please refer to Section IX . Special Interest Projects (SIPs) Descriptions of this announcement under Award Administration of the SIP description for details. You must provide CDC with an original, plus two hard copies of the following reports: 1.

Interim/Grant Progress Report, (use form PHS 2590, OMB Number 0925-0001, rev. 9/04 as posted on the CDC website) no less than 120 days prior to the end of the current budget period. The progress report will serve as your non-competing continuation application.

2. Annual Progress Report, due 90 days after the end of the budget period. Financial status report, no more than 90 days after the end of 3.

Final financial and performance reports, no more than 90 days after the end of the project period. These reports must be forward by U.S. Postal Service or Express Delivery to the Grants Management Specialist listed in the Agency Contacts section of this announcement.

Although the financial plans of the CIO(s) provide support for this program, awards pursuant to this funding opportunity are contingent upon the availability of funds, evidence of satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the Federal government.

We encourage your inquiries concerning this funding opportunity and welcome the opportunity to answer questions from potential applicants. Inquiries may fall into three areas: scientific/research, peer review, and financial or grants management issues: 1.

Scientific/Research Contacts: Brenda Colley Gilbert, PhD, MSPH Center for Chronic Disease Prevention and Health Promotion Center-Williams Building, MS K-92 Office of Extramural Research National Center for Chronic Disease Prevention and Health Promotion 4770 Buford Highway, MS K-92 3. Financial or